Quality of life in diabetes

Harsimran Singh and Clare Bradley

(2006)

Harsimran Singh and Clare Bradley (2006) Quality of life in diabetes. International Journal of Diabetes in Developing Countries , 26 (1). pp. 7-10. ISSN 0973-3930

Our Full Text Deposits

Full text access: Open

Full Text - 409.95 KB

Links to Copies of this Item Held Elsewhere


Abstract

This article emphasises the need to assess quality of life (QoL) as a key outcome of diabetes management and introduces the linguistically validated and culturally adapted, Hindi and Punjabi versions of an individualised questionnaire (the ADDQoL) to assess the impact of diabetes on the QoL of Indian people with diabetes. ADDQoL findings in the UK indicated that approaches to diabetes management were needed that allowed for dietary freedom. Use of the ADDQoL in the subsequent DAFNE (Dose Adjustment For Normal Eating) trial showed significant benefits to quality of life from training in insulin dose adjustment to provide for dietary freedom without loss of diabetes control. ADDQoL findings from research in India have helped highlight the negative impact of diabetes on various life domains of Indian people with diabetes, especially their self-confidence, their family life and their freedom to eat as they wish. It is suggested that targets of diabetes management are more likely to be achieved if the importance of protecting and improving QoL is recognised and monitored alongside biomedical outcomes such as blood glucose levels.

Information about this Version

This is a Published version
This version's date is: 03/2006
This item is peer reviewed

Link to this Version

https://repository.royalholloway.ac.uk/items/5b4b4e9a-71a3-22d7-f55a-1663055a397e/1/

Item TypeJournal Article
TitleQuality of life in diabetes
AuthorsSingh, Harsimran
Bradley, Clare
Uncontrolled KeywordsClinical trial, diabetes, diabetes-specific measures, dietary freedom, health care, linguistic validation, Patient Reported Outcomes (PRO), Quality of Life (QoL)
DepartmentsFaculty of Science\Psychology

Identifiers

doi10.4103/0973-3930.26882

Deposited by () on 21-May-2010 in Royal Holloway Research Online.Last modified on 22-Dec-2010

Notes

(C) 2006 Medknow Publications, whose permission to mount this version for private study and research is acknowledged.  The repository version is the author's final draft.

References

1.Bradley C. Measuring quality of life in diabetes. Diabetes Ann 1996:207–27.


2.Joyce CR. Requirements for the assessments of individual quality of life. In: Bradley C, editor. Quality of life following renal failure: Psychological challenges accompanying high technology medicine. Harwood Academic Publishers: Chur, Switzerland; 1994. p. 43–54.


3.Walker J, Bradley C. Assessing the quality of life of adolescents with diabetes: using the SEIQoL, DQoL, patient and diabetes specialist nurse ratings. Pract Diabetes Int 2002;19:141–4.


4.UK Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999;22:1125–36.


5.Bradley C. Importance of differentiating health status from quality of life. Lancet 2001;357:7–8.


6.Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright
R. The development of an individualised questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999;8:S64–9.


7.Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metabol Res Rev 2002;18:S64–9.


8.McGee HM, O’Boyle CA, Hickey A, O’Malley K, Joyce CR. Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol Med 1991;21:749–59.


9.DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002;325:746.


10.Woodcock AJ, Julious SA, Kinmonth AL, Campbell MJ. Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Qual Life Res 2001;10:661–70.


11.Muhlhauser I, Jorgens V, Berger M, Graninger W, Gurtler W, Hornke L, et al. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: Improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 1983;25:470–6.


12.Howorka K. Functional Insulin Therapy. Second ed. Berlin Heidelberg: Springer-Verlag: 1996.


13.Singh H, Plowright R, Bradley C. Linguistic validation of diabetes-specific psychological measures in Hindi and Punjabi [abstract]. Proc Br Psychol Soc 2004;13:88–9.


14.Acquadro C, Conway K, Giroudet I, Mear I. Linguistic Validation Manual for Patient-Reported Outcomes (PRO) Instruments. Mapi Research Institute: Lyon; 2004.


15.Boynton PM, Greenhalgh T. Selecting, designing and developing your questionnaire. BMJ 2004;328:1312–5.


Details